NCT07405086 2026-02-12Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyOHSU Knight Cancer InstitutePhase 2 Not yet recruiting160 enrolled
NCT07358884 2026-01-22First in Human Study of QLS5316 in Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1 Not yet recruiting300 enrolled
NCT07036185 2025-06-25A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid TumorsShanghai Bao Pharmaceuticals Co., Ltd.Phase 1 Not yet recruiting66 enrolled